CitoxLAB cites LAB takeover as driver and hints at collaboration with clinical CROs
CiToxLAB says LAB Research acquisition was key driver for growth in H1 2012 and hints at future collaborations with clinical CROs.
Archives for October 3, 2012
EXCLUSIVE
EMA biosimilar guidance welcomed but has further to go, say EGA, Aptuit and Charles River
Latest EMA biosimilar guidance on reference products is a “major breakthrough” but there is still work to do, say industry experts.